A Study of the Rules for Insulin Dosing in Patients Using Multiple Daily Injections

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2010 by Diabetes Care Center.
Recruitment status was  Recruiting
Information provided by:
Diabetes Care Center
ClinicalTrials.gov Identifier:
First received: January 7, 2010
Last updated: January 8, 2010
Last verified: January 2010
This study will be conducted in subjects with Type 1 diabetes mellitus on multiple daily insulin injections to determine the correct insulin dosing formulas. Subjects will be evaluated using continuous glucose monitoring.

Condition Intervention
Diabetes Mellitus Type 1
Drug: Lispro Insulin and glargine insulin

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: A Study of the Rules for Insulin Dosing in Patients Using Multiple Daily Injections

Resource links provided by NLM:

Further study details as provided by Diabetes Care Center:

Primary Outcome Measures:
  • Determine the mean value for the slop between the variables of total daily dose versus total basal dose. [ Time Frame: Two weeks ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Determine the slope between the other variables: weight, total daily dose, total basal dose, insulin correction carbohydrate rate, correction factor [ Time Frame: Two weeks ] [ Designated as safety issue: No ]

Estimated Enrollment: 50
Study Start Date: January 2010
Estimated Study Completion Date: October 2010
Estimated Primary Completion Date: August 2010 (Final data collection date for primary outcome measure)
Intervention Details:
    Drug: Lispro Insulin and glargine insulin
    Continuous glucose sensor will be inserted. Subject will be on an isocaloric diet and CGM downloaded daily. Insulin basal and bolus will be adjusted based upon treatment goals until goals reached
Detailed Description:
Subjects with stable type 1 diabetes mellitus on multiple daily insulin injections including basal and bolus will be selected in order to determine the correct insulin dosing formulas. Subjects will be placed on continuous glucose sensor (CGMS) and an isocaloric diet. Subjects will have the CGMS downloaded daily and the insulin doses adjusted if necessary. Subject will do four SMBGs daily to calibrate CGMS and on last day a 7-point SMBG. subjects will be on lispro and glargine insulin. Basal insulin will be once a day.

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Age: >17 years
  • Type 1 diabetes
  • Diabetes duration > 3 months
  • On treatment with multiple daily injections either one or more basal insulin injections each day for 6 weeks
  • HbA1c <9.0%
  • Stable HbA1c in the proceeding 3 months (i.e., change <1%)
  • Demonstrated adherence to visits and instructions
  • Attend a class in meal carbohydrate content estimation or have demonstrated knowledge of carbohydrate counting

Exclusion Criteria:

  • Major stress event during or for 6 weeks before the evaluation
  • Taking a medication that can alter insulin sensitivity
  • Within one week of menses
  • Unstable eating or activity pattern
  • Pregnancy
  • Weight gain of > 1.5 kg during the preceding 3 months
  • Serum creatinine of >1.5 mg/dl
  • Active liver disease
  • Evidence of autonomic neuropathy, especially gastroparesis
  • Any antidiabetic medication other than insulin
  • Treatment with continuous subcutaneous insulin infusion
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01045954

Contact: Gary W Wolfe, RN 831-769-9355 gwolfe@diabetescarecenter.com

United States, California
Diabetes Care Center Recruiting
Salinas, California, United States, 93901
Contact: Gary S Wolfe, RN    831-769-9355    gwolfe@diabetescarecenter.com   
Principal Investigator: Allen B King, MD         
Sub-Investigator: Dawn Clark, NP         
Sponsors and Collaborators
Diabetes Care Center
Principal Investigator: Allen B. King, MD Diabetes Care Center
  More Information

Walsh J, Roberts R. Pumping Insulin. 3rd Edition, San Diego, Torrey Pines Press. 2000
Bode BW. Insulin Pump Therapy. In, Therapy for diabetes Mellitus and Related Disorders, fourth edition, Lebovitz H. Ed, Alexandria, VA, American Diabetes Association, 2004, p224-231
Davidson PC, Hebblewhite HR, Bode BW, et al. Statistically based CSII parameters correction factor, CF (1700 rule) carbohydrate-to-insulin ratio, CIR (2.8 rule) and basal-to-total ration. Diabetes Technol Ther. 2003; 3:237

Responsible Party: Allen B. King, MD, Diabetes Care Center
ClinicalTrials.gov Identifier: NCT01045954     History of Changes
Other Study ID Numbers: DCC 02-09
Study First Received: January 7, 2010
Last Updated: January 8, 2010
Health Authority: United States: Institutional Review Board

Keywords provided by Diabetes Care Center:
diabetes mellitus type 1
continuous glucose monitoring

Additional relevant MeSH terms:
Diabetes Mellitus
Diabetes Mellitus, Type 1
Autoimmune Diseases
Endocrine System Diseases
Glucose Metabolism Disorders
Immune System Diseases
Metabolic Diseases
Hypoglycemic Agents
Pharmacologic Actions
Physiological Effects of Drugs

ClinicalTrials.gov processed this record on November 27, 2015